Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis

Hepatology

Volumn 31, Issue 4, 2000, Pages 899-906

  Majno, Pietro E ^a,b   Sarasin, François P ^a   Mentha, Gilles ^a   Hadengue, Antoine ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; MEDICAL LITERATURE; PRIORITY JOURNAL; SALVAGE THERAPY; STATISTICAL MODEL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0034077090     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/he.2000.5763     Document Type: Article

References (16)

1. Hashem B, El-Serag, Andrew C. The increasing incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
2. Sarasin FP, Giostra E, Mentha G, Hadengue A. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. HEPATOLOGY 1998;28: 436-442.
3. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, Perrin H, et al. Influence of pre operative transarterial lipiodol chemoembolisation on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-703.
4. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, Tzakis AG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221-229.
5. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation. World J Surg 1991;15:270-285.
6. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218:145-151.
7. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection for hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114-117.
8. Bennett WG, Inoue Y, Beck JR, Wong JB, Pauker SG, Davis GL. Estimates of the cost-effectiveness of a single course of Interferon- 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med 1997;127: 855-865.
9. Maimark D, Krahn MD, Naghie G, Redelmeier DA, Detsky AS. Primer on medical decision analysis. Part 5 working with Markov processes. Med Decis Making 1997;17:152-159.
10. Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 1998;129:787-796.
11. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montaho. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
12. D'Amico G, Morabito A, Pagliaro L, Marubini E, and the Liver Study Group of "V Cervello" Hospital. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986;31:468-475.
13. Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, and the Copenhagen Study Group for Liver Diseases. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. HEPATOLOGY 1984;4:430-435.
14. Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, Caballeria J, et al. Compensated cirrhosis: natural history and prognostic factors. HEPATOLOGY 1987;7:122-128.
15. Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P, Sanchez-Tapias J, Christensen E, et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepatol 1994;21:656-666.
16. United Network for Organ Sharing annual report 1998. http://www. unos.org